82 results
424B4
ATXI
Avenue Therapeutics Inc
11 Oct 22
Prospectus supplement with pricing info
8:27am
objectives, our ability to raise additional capital and our ability to implement our business strategy, any of which may have a material adverse effect … plan and implement our strategy, we may need to obtain additional financing and may choose to raise additional funds through strategic collaborations
8-K
EX-99.1
4ftv7w
16 Feb 22
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
7:39am
424B5
8a3z156lscy
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
sutd6mf 6ebmn2
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
iduog
10 Nov 21
Prospectus supplement for primary offering
5:25pm
424B5
qscyd2
9 Nov 21
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
j1t 2pvec8
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am